Ollin Biosciences raises $156.2 million in Rule 506(b) equity offering
Ollin Biosciences, a Delaware biotechnology corporation, has sold $156,249,990 of a $330,000,000 private equity offering under Regulation D Rule 506(b).
$156M$330Mequity
Company
SEC filing news and material events for Ollin Biosciences, Inc., briefed from primary-source filings.
1 story
Ollin Biosciences, a Delaware biotechnology corporation, has sold $156,249,990 of a $330,000,000 private equity offering under Regulation D Rule 506(b).